Progyny (NASDAQ: PGNY) reported Q2 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $279.4 million versus the consensus estimate of $261.91 million.

For earnings history and earnings-related data on Progyny (PGNY) click here.